Hypothesis

7 Matching Annotations

Sep 2026
www.biorxiv.org www.biorxiv.org

Cell-state–dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells

1
1. scibot 03 Sep 2026
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.64898/2026.08.25.746864
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

biorxiv.org/content/10.64898/2026.08.25.746864v1
Dec 2023
www.sciencedirect.com www.sciencedirect.com

Human inherited CCR2 deficiency underlies progressive polycystic lung disease

1
1. scibot 29 Dec 2023
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.1016/j.cell.2023.11.036
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867423013235
www.sciencedirect.com www.sciencedirect.com

ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells

1
1. scibot 02 Dec 2023
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.1016/j.ccell.2023.11.004
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823003951
Nov 2023
www.sciencedirect.com www.sciencedirect.com

A phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab in patients with advanced solid tumors

1
1. scibot 02 Nov 2023
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.1016/j.xcrm.2023.101242
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379123004196
Jan 2023
www.sciencedirect.com www.sciencedirect.com

A universal MHCII technology platform to characterize antigen-specific CD4+ T cells

1
1. scibot 19 Jan 2023
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.1016/j.crmeth.2022.100388
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2667237522002934
Nov 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

1
1. scibot 16 Nov 2021
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.1016/j.isci.2021.103353
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8552693/
Apr 2021
www.sciencedirect.com www.sciencedirect.com

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

1
1. scibot 24 Apr 2021
  
  in Public
  
  RRID:AB_400297
  
  DOI: 10.1016/j.cell.2020.08.053
  
  Resource: (BD Biosciences Cat# 347413, RRID:AB_400297)
  
  Curator: @scibot
  
  SciCrunch record: RRID:AB_400297
  
  What is this?
  
  RRID:AB_400297
Visit annotations in context

Tags

RRID:AB_400297

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867420311417